Principal Securities, Inc. Axsome Therapeutics, Inc. Transaction History
Principal Securities, Inc.
- $4.14 Trillion
- Q3 2024
A detailed history of Principal Securities, Inc. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 8 shares of AXSM stock, worth $785. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8
Previous 3
166.67%
Holding current value
$785
Previous $242,000
197.11%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AXSM
# of Institutions
326Shares Held
37.7MCall Options Held
912KPut Options Held
855K-
Rtw Investments, LP New York, NY4.19MShares$411 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$392 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$324 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$232 Million34.46% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$103 Million2.99% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.21B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...